Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Lead
M.D. Anderson Cancer Center
Primary Objective: • To evaluate the efficacy of cetuximab in patients with advanced (unresectable) or metastatic, chordoma based on response rate according to RECIST1.1. Secondary Objectives: * To evaluate response rate according to Choi criteria * To evaluate the safety and tolerability of cetuximab for chordoma patients * To evaluate the progression-free survival (median, at 24 weeks, and 52 weeks) and to determine the overall survival (median). * To evaluate the ratio of PFS on study compared to PFS from prior treatment
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted